NCT03975829 2026-02-13Pediatric Long-Term Follow-up and Rollover StudyNovartisPhase 4 Active not recruiting163 enrolled
NCT03340506 2026-02-03Dabrafenib and/or Trametinib Rollover StudyNovartisPhase 4 Recruiting100 enrolled